Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 373

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 373
---
 to adopt pursuant to the listing standards of any national securities exchange or association on which our securities
are listed or as is otherwise required by the Dodd-Frank Act or other applicable laws. The administrator also may specify in an award
agreement that the participant’s rights, payments or benefits with respect to an award will be subject to reduction, cancellation,
forfeiture or recoupment upon the occurrence of certain specified events. The administrator may require a participant to forfeit, return
or reimburse us all or a portion of the award or shares issued under the award, any amounts paid under the award and any payments or
proceeds paid or provided upon disposition of the shares issued under the award in order to comply with such clawback policy or applicable
laws.

73

Amendment and Termination

The administrator has the authority to amend,
suspend or terminate the 2022 Plan provided such action does not impair the existing rights of any participant. The 2022 Plan automatically
will terminate on November 22, 2032, unless it is terminated sooner.

Non-Employee Director Remuneration Policy

Our Board has not adopted a non-employee director
remuneration policy.

Clawback Policy

On November 23, 2023, our Board adopted an executive
compensation recoupment policy consistent with the requirements of the Exchange Act Rule 10D-1 and the Nasdaq listing standards thereunder,
to help ensure that incentive compensation is paid based on accurate financial and operating data, and the correct calculation of performance
against incentive targets. Our policy addresses recoupment of amounts from performance-based awards paid to all corporate officers, including
awards under our equity incentive plans, in the event of a financial restatement to the extent that the payout for such awards would
have been less, or in the event of fraud, or intentional, willful or gross misconduct that contributed to the need for a financial restatement.

Board Compensation

In November and December 2022, we signed agreements
with four directors (Cheryl Xu, Paul Field, Charles Allen and Stephen Toovey). Each director receives cash compensation of $11,250 per
quarter. In addition, the two non-audit committee chairs (Mr. Toovey and Mr. Field) receive $1,250 per quarter and the audit committee
chair (Mr. Allen) receives an additional $2,000 per quarter. On July 11, 2023, each director received (i) a one-off issuance of 167